SCPS OTC
Scopus BioPharma Inc.
1W: +0.0%
1M: +0.0%
3M: -20.0%
YTD: +0.0%
1Y: +33.3%
3Y: -99.1%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±30.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$392K
-95.2% ▼
5Y CAGR: +13.0%
Total Liabilities
$7M
+78.8% ▲
5Y CAGR: +131.8%
Shareholders Equity
-$7M
-263.4% ▼
Cash & Investments
$125K
-98.4% ▼
5Y CAGR: -4.7%
Total Debt
$0
+0.0% ▲
Net Debt
-$125K
+98.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2K | $37K | $2M | $8M | $125K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $2K | $37K | $2M | $8M | $125K |
| Net Receivables | $28K | $562 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $626K | $0 | $0 | $265K |
| Total Current Assets | $133K | $768K | $2M | $8M | $390K |
| Property, Plant & Equip. | $0 | $4K | $2K | $3K | $2K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $0 | $4K | $2K | $3K | $2K |
| Total Assets | $133K | $772K | $2M | $8M | $392K |
| — Liabilities — | |||||
| Accounts Payable | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $2M | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $24K | $0 | $0 | $0 | $253K |
| Total Current Liabilities | $138K | $855K | $4M | $4M | $7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $2M | $0 | $0 |
| Total Liabilities | $138K | $855K | $4M | $4M | $7M |
| — Equity — | |||||
| Common Stock | $11K | $13K | $15K | $21K | $21K |
| Retained Earnings | -$949K | -$4M | -$15M | -$41M | -$53M |
| Accumulated OCI | -$10K | -$33K | -$68K | -$87K | -$5K |
| Total Stockholders Equity | -$5K | -$83K | -$2M | $4M | -$7M |
| Total Liabilities & Equity | $133K | $772K | $2M | $8M | $392K |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $2M | $0 | $0 |
| Net Debt | -$2K | -$37K | $452K | -$8M | -$125K |
| Total Investments | $0 | $0 | $0 | $0 | $0 |